Northern Virginia Holistic Primary Care

UNDERSTANDING

PERIMENOPAUSE

&

MENOPAUSE

PERIMENOPAUSE

Gradual decline of ovarian reserve 8+ years prior to menopause

Definition by STRAW Criteria: time of hormonal changes at 2-8 yr prior to menopause

         Early: consistent 7+ day variability in cycle

         Late:  intervals between periods 60+ days


LABS

Gradual decline in progesterone over years 

Estradiol is erratically high/low initially, eventially drops low


MENOPAUSE

Most women will enter menopause between the ages of 45-55

Early menopause: younger than 45

Clinical definition of menopause: 1 year after your final menstrual period*

*Addressing symptoms & therapy should not be based on this single definition 


No labs are required to diagnose menopause but usually FSH is very high and estradiol is very low

Postmenopause: every day after your date of menopause



COMMON SYMPTOMS

IN BOTH

PERIMENOPAUSE & MENOPAUSE

Hot flashes, night sweats

Brain fog/memory decline/difficulty with concentration

Mood: anxiety/depression

Fatigue

Insomnia/sleep disturbances

Weight gain

Loss of libido, vaginal dryness, pain with intercourse

Reduced bone mineral density (usually asymptomatic at this stage)

If you are suffering from these symptoms, you are not alone. 

Unfortunately, we see this list commonly in patients who come to us. 

7 years ago when patients on HRT came to us and described how hormone therapy had restored their lives, we were listening. 

Their experiences did not add up with the well known Women’s Health Initiative (WHI) studies and standard clinical guidelines. 

We began monitoring hormones then but promised to expand to prescribing hormone therapy when we had extensively studied the literature and completed menopause & HRT training – to know we were offering our patients the safest and most beneficial options whether general practices and guidelines had caught up or not. 

WHERE ARE YOUR HORMONES COMING FROM IN MENOPAUSE?

Ovaries will no longer make estradiol or progesterone, but they continue to make testosterone (gradually declines with age)

Adrenal glands will now take over androgen production. These androgen hormones will convert mostly in fat tissue to estrogens. 

90% of the postmenopausal estrogens will be made in peripheral fat tissue.

If there was ONE POINT to understand about menopause-

This is NOT limited to the reproductive system 

Estrogen, progesterone, and testosterone affect 

ALL of our organs.

BENEFITS OF
ESTROGEN THERAPY

Reduces risk of osteoporosis and fractures

Reduces cardiovascular risk

May improve muscle mass

May improve sleep

May improve cognition

Better weight management

Improves mood 

Improves skin elasticity and health

May reduce hair loss

May reducing joint pain

Reduce hot flashes

Improve vaginal dryness, pain with intercourse, vaginal health

Reduces/prevent recurrent urinary tract infections


BENEFITS OF
PROGESTERONE THERAPY

Prevention of endometrial hyperplasia and endometrial cancer

Improves bone mineral density (promotes new bone growth)

Improves mood disorders (particularly anxiety)

Improves sleep

Reduces hot flashes

May have brain protective effects



A LITTLE ABOUT TESTOSTERONE…

While men have much more, this is not only a male hormone. 

Women have more androgen receptors than estrogen receptors.

To glimpse what this hormone is doing, we have to understand androgen receptors in women are found in:

 

Hair follicles, skin, brain, spinal cord, nerves, eyes, ears, thyroid, 

cardiovascular tissue, breasts, lungs, uterus, vagina, bladder, 

gastrointestinal tract, kidneys, liver, adrenal glands, 

muscle, joints, fat tissue, bone, and other endocrine glands

Yet the only approved indication by clinical guidelines for treating a woman who has measured very low testosterone levels is: 

Hypoactive Sexual Desire Disorder

They acknowledge the importance of correcting all other hormones, yet do not have enough evidence testosterone levels are important for women. 

At the menopause clinic, proper testing and treatment around this will be a personal discussion with our patient. We do avoid supraphysiologic dosing as there can be serious consequences down the road with this.

There are also risks to consider with hormone therapy. These are generally outweighed by the benefits, but should be discussed thoroughly with your doctor. Many of these risks can be mitigated by product type and route of administration.

WHY WE TEST:

After decades of practicing medicine, we know the standard “one size fits all” approach does not work.

Current practices argue that it is sufficient to treat symptoms and ignore levels. We disagree.

Patients come to us from different practices with extremely high levels of unmonitored hormones, while others have levels which remain below the menopausal range despite treatment. Neither are asymptomatic, and neither are benefitting from the assumption that absorption and hormone metabolism will be the same in all.  We test, adjust, and offer continued monitoring. 

Hormonal Replacement Therapy is not the single answer alone.  Your hormones work in symphony with the rest of you – in order to do this properly – we can’t leave your HPA axis, HPO axis, and thyroid stuck in dysfunctional patterns.

We look at your hormone production & metabolism, adrenal health markers, inflammation, and detoxing capacity to understand where to meet you in hormone replacement. When hormones can be optimized to match your needs, you will find benefit from a dose designed to your own body. 

Ongoing cardiovascular, endometrial, breast, and bone surveillance is necessary.

 How do you metabolize your estrogen? This is a critical question to address for both hormone replacement therapy as well as to reducing modifiable risk factors for breast cancer and endometriosis. Mammogram screening is an important tool, but we choose to take a proactive approach with our patients – evaluate their estrogen metabolism pathways, and then work to optimize these paths. These efforts can reduce the risk of developing breast cancer in the future.

  One of the reasons we gain weight in perimenopause –

 

 

As ovarian estrogen drops, FSH stimulates

FAT tissue growth

since fat tissue produces compensatory estrogen

         YET, HRT in this critical period of weight gain

is often DELAYED

YES, hormones are fluctuating at this time, but 

that just means

we need to learn to test properly

We are in an epidemic of hormonal dysregulation over the past 50 years – 

from severe PMS/PMDD to PCOS & endometriosis to infertility to adrenal dysfunction to 

severe and earlier menopause and perimenopause transition. 

We need to treat this conscientiously.

Guidelines still don’t recommend testing for perimenopause or menopause since it’s complicated and difficult to decipher.

Yes, it IS complicated, 

but that just means the medical community needs to 

TRY HARDER FOR WOMEN – 

We absolutely DO test with complete evaluations

 

Testing has been proven reliable when done properly*

*We will be providing details on this with research study references. 

MORE IMPORTANTLY,

THE “NO NEED TO TEST” ATTITUDE CAUSES HARM

BELOW ARE A FEW CASES WE HAVE SEEN

Follow us on Instagram & Facebook:

The materials and content mentioned on this site are intended as general information and should not be used as a substitute for personal medical advice, diagnosis, or treatment.  This website does not qualify as creating a provider-patient relationship between us and any user of the website

Menopause care- Perimenopause Treatment- Menopause specialists- Menopause clinic